HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Incilay Lay Selected Research

Yunis Varon syndrome

1/2021A new UHPLC-MS/MS method for the screening of urinary oligosaccharides expands the detection of storage disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Incilay Lay Research Topics

Disease

3Inflammation (Inflammations)
10/2019 - 02/2016
2Cystic Fibrosis (Mucoviscidosis)
04/2022 - 01/2020
2Diabetes Mellitus
01/2021 - 01/2020
1Cardiomyopathies (Cardiomyopathy)
06/2022
1Lung Diseases (Lung Disease)
04/2022
1Asthma (Bronchial Asthma)
03/2022
1Vitamin D Deficiency
01/2022
1Genetic Risk Score
01/2022
1Lead Poisoning (Poisoning, Lead)
01/2022
1Abdominal Obesity
05/2021
1Acromegaly
01/2021
1Lung Neoplasms (Lung Cancer)
01/2021
1Osteoporosis
01/2021
1Neoplasms (Cancer)
01/2021
1Glycogen Storage Disease Type II (Pompe's Disease)
01/2021
1Yunis Varon syndrome
01/2021
1Multiple Sclerosis
01/2021
1Infertility (Sterility)
01/2021
1Absent corpus callosum cataract immunodeficiency
01/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Glycogen Storage Disease Type IIb
01/2021
1Adenoma (Adenomas)
01/2021
1Kidney Diseases (Kidney Disease)
12/2020
1Nephritis
12/2020
1IgA Vasculitis (Purpura, Schoenlein Henoch)
12/2020
1Obesity
06/2020
1Ciliary Motility Disorders (Primary Ciliary Dyskinesia)
01/2020
1Type 2 Diabetes Mellitus (MODY)
01/2020
1Apnea
12/2019
1Obstructive Sleep Apnea
12/2019
1Hemolysis
10/2019
1Anemia
10/2019
1Sickle Cell Anemia (Hemoglobin S Disease)
10/2019
1Rosacea (Acne Rosacea)
08/2019
1Coronary Artery Disease (Coronary Atherosclerosis)
07/2019
1Ischemia
07/2019
1Psoriasis (Pustulosis Palmaris et Plantaris)
02/2016

Drug/Important Bio-Agent (IBA)

6OxysterolsIBA
03/2022 - 07/2019
4Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2016
37-ketocholesterolIBA
03/2022 - 07/2019
2Malondialdehyde (Propanedial)IBA
03/2022 - 12/2019
2LipidsIBA
01/2022 - 10/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2019 - 02/2016
1FollistatinIBA
06/2022
1chitotriosidaseIBA
04/2022
1Immunoglobulin E (IgE)IBA
03/2022
1Dietary Fats (Dietary Fat)IBA
01/2022
1hydroxide ionIBA
01/2022
125-hydroxyvitamin DIBA
01/2022
1SphingosineIBA
01/2022
1Phosphates (Orthophosphate)IBA
01/2022
1AdiponectinIBA
05/2021
1maltoheptaoseIBA
01/2021
1GlycogenIBA
01/2021
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2021
1Prostaglandin D2IBA
12/2020
15-methyltetrahydrofolateIBA
12/2020
1AcidsIBA
12/2020
1PorphobilinogenIBA
12/2020
1Proteins (Proteins, Gene)FDA Link
06/2020
1CopperIBA
01/2020
1ZincIBA
01/2020
1CeramidesIBA
01/2020
1SphingomyelinsIBA
01/2020
13,5-diisopropylsalicylic acid (DIPS)IBA
12/2019
1CholesterolIBA
10/2019
1Ferritins (Ferritin)IBA
10/2019
1IronIBA
10/2019
1ImmunosorbentsIBA
08/2019
1EnzymesIBA
08/2019
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2019
1ischemia-modified albuminIBA
07/2019

Therapy/Procedure

1Chelation Therapy (Therapy, Chelation)
01/2022